1986
DOI: 10.1016/s0025-6196(12)61391-3
|View full text |Cite
|
Sign up to set email alerts
|

Elevation of Carcinoembryonic Antigen in Cerebrospinal Fluid Among Patients With Meningeal Carcinomatosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
20
1
2

Year Published

1995
1995
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(23 citation statements)
references
References 7 publications
0
20
1
2
Order By: Relevance
“…Although most of these parameters are highly sensitive for LM, their specificity is low because infectious CNS diseases also showed abnormal CSF findings or this group of patients was not studied for comparison. In contrast to VEGF (Stockhammer et al, 2000), the CSF levels of some biomarkers are highly influenced by their serum concentrations or may not allow to differentiate between leptomeningeal and epidural growth (Klee et al, 1986). Compared with these previously markers, VEGF appears to offer a favourable profile of sensitivity and specificity.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Although most of these parameters are highly sensitive for LM, their specificity is low because infectious CNS diseases also showed abnormal CSF findings or this group of patients was not studied for comparison. In contrast to VEGF (Stockhammer et al, 2000), the CSF levels of some biomarkers are highly influenced by their serum concentrations or may not allow to differentiate between leptomeningeal and epidural growth (Klee et al, 1986). Compared with these previously markers, VEGF appears to offer a favourable profile of sensitivity and specificity.…”
Section: Discussionmentioning
confidence: 96%
“…Many proteins have been investigated as diagnostic or prognostic CSF parameters in LM patients during the last 30 years, including carcinoembryonic antigen (CEA; Klee et al, 1986), lactate dehydrogenase (LDH; Seidenfeld and Marton 1979;Van Zanten et al, 1986), beta-glucuronidase and beta-microglobulin (Ongerboer de Visser et al, 1985), a combination of tissue polypeptide antigen and CK-BB (Bach et al, 1993), fibronectin (Weller et al, 1990), and the epithelial HMFG-1 antigen (Moseley et al, 1989). Although most of these parameters are highly sensitive for LM, their specificity is low because infectious CNS diseases also showed abnormal CSF findings or this group of patients was not studied for comparison.…”
Section: Discussionmentioning
confidence: 99%
“…Particular tumor markers such as carcinoembryonic antigen (CEA) from adenocarcinomas and ␣-fetoprotein and ␤-human chorionic gonadotropin from testicular cancers and primary extragonadal CNS tumors can be relatively specific for NM when elevated in CSF in the absence of markedly elevated serum levels [16,26]. Nonspecific tumor markers such as creatine-kinase BB isoenzyme, tissue polypeptide antigen, ␤ 2 -microglobulin, ␤-glucoronidase, lactate dehydrogenase isoenzyme-5, and more recently vascular endothelial growth factor can be strong indirect indicators of NM, but none are sensitive enough to improve the cytological diagnosis [27][28][29][30][31]. The use of these biochemical markers can be helpful as adjunctive diagnostic tests and, when followed serially, to assess response to treatment.…”
Section: Csf Examinationmentioning
confidence: 99%
“…Increased concentrations of CEA (12,13), a-fetoprotein and b-human chorionic gonadotropin (bHCG) (14) have been observed in the CSF of patients with LM, but the amount of TM in CSF due to filtration and/or to dysfunction of the blood/ CSF barrier was not always evaluated correctly (15). In most cases, TM levels have been considered diagnostic for LM when concentrations in CSF were greater than those observed in serum (16).…”
Section: Introductionmentioning
confidence: 99%